PKM and cancer: To this end, we determined the intracellular concentration of PKM2, using targeted proteomics, and the range of intracellular concentrations of FBP, Ser and Phe (denoted as [X]ic, where X is the respective metabolite), using metabolomics, in three human cancer cell lines (see Materials and methods).